Sarkis Meterissian
Director/Board Member chez DEFENCE THERAPEUTICS INC.
Fortune : 240 000 $ au 31/03/2024
Profil
Sarkis Meterissian is currently the Co-Chairman at Quebec Breast Cancer Foundation, an Independent Director at Defence Therapeutics Inc, Director at Muhc Cedars Breast Clinic, and a Professor at McGill University.
Previously, he served as the President of The Canadian Society of Surgical Oncology from 2007 to 2009 and as the President of Breast Surgery International from 2013 to 2015.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 21/12/2023 | 192 000 ( 0,43% ) | 240 000 $ | 31/03/2024 |
Postes actifs de Sarkis Meterissian
| Sociétés | Poste | Début |
|---|---|---|
| DEFENCE THERAPEUTICS INC. | Director/Board Member | 05/01/2021 |
| Quebec Breast Cancer Foundation | Chairman | 01/01/2012 |
| McGill University | Corporate Officer/Principal | - |
| Muhc Cedars Breast Clinic | Director/Board Member | - |
Anciens postes connus de Sarkis Meterissian
| Sociétés | Poste | Fin |
|---|---|---|
| Breast Surgery International | President | 01/01/2015 |
| The Canadian Society of Surgical Oncology | President | 01/01/2009 |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DEFENCE THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
| Quebec Breast Cancer Foundation | |
| The Canadian Society of Surgical Oncology | |
| Breast Surgery International | |
| Muhc Cedars Breast Clinic |
